The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

Europe Next Generation Sequencing Market Overview

The growth of the European next-generation sequencing (NGS) market is driven by technological advancements and developments in genomics. However, the market's progress is hindered by a scarcity of skilled professionals and the high risks associated with genetic data. Innovations in molecular biology have equally enhanced sequencing procedures. Many industry players have launched innovative NGS technologies in recent years, leading to the creation of genetically modified organisms and the New Bioeconomy. For instance, in October 2018, Roche launched three new AVENIO Tumor Tissue Analysis Kits. In addition to these, three dominant systems—Roche GS FLX, Illumina HiSeq 2000, and AB SOLiD—have continued to shape the market landscape.

Europe Next Generation Sequencing Market Strategies

Strategic insights for the European NGS market provide a data-driven analysis of the industry landscape, including trends and key players. These insights offer actionable recommendations that enable readers to differentiate themselves by identifying untapped segments or developing unique value propositions. By leveraging data analytics, these insights help stakeholders anticipate market shifts and position themselves for long-term success. A future-oriented perspective is essential, empowering readers to make informed, profitable decisions. Effective strategic insights are critical for achieving business objectives, whether you are an investor, manufacturer, or other stakeholder in this dynamic European market.

Europe Next Generation Sequencing Market Insights

The geographic scope of a business in the European NGS market refers to its specific areas of operation and competition. Understanding local distinctions, such as consumer preferences and regulatory environments, is crucial for tailoring effective strategies. By identifying underserved areas or adapting their offerings to meet local demands, businesses can expand their reach. This clear market focus allows for more efficient resource allocation and targeted marketing campaigns, ultimately leading to better positioning against local competitors. This strategic approach is vital for driving growth and ensuring success in the targeted regions.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005459

EUROPE NEXT GENERATION SEQUENCING - MARKET SEGMENTATION

By Product

• Consumables

• Services

• Platforms

By Technology

• Genome Sequencing

• Exome Sequencing

• Resequencing & Targeted Sequencing

• Other

By Application

• Diagnostics

• Drug Discovery

• Precision Medicine

• Others

By End User

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Hospitals & Clinics

• Others

By Geography

• Europe

• UK

• Germany

• France

Company Profiles

• Illumina, Inc.

• Thermo Fisher

• Qiagen N.V.,

• Beijing Genomics Institute

• PerkinElmer, Inc.

• F.Hoffman-La Roche Ltd.

• Agilent Technologies

• Eurofins Scientific

• Oxford Nanopore Technologies Ltd.

• Macrogen Inc.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications